sisomicin has been researched along with imipenem, anhydrous in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Aggen, JB; Armstrong, ES; Diokno, R; Dozzo, P; Feeney, LA; Gliedt, MJ; Goldblum, AA; Gomez, M; Hildebrandt, DJ; Kubo, A; Linsell, MS; Lopez, S; Matias, RD; Miller, GH; Moser, HE; Wlasichuk, KB | 1 |
Aznar, J; García Iglesias, MC; Perea, EJ | 1 |
Culebras, E; García-Salguero, C; Picazo, JJ; Rodríguez-Avial, I | 1 |
Bush, K; Kashikar, A; Zhang, Y | 1 |
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
Kasimati, A; Magkafouraki, E; Maraki, S; Mavromanolaki, VE; Moraitis, P; Scoulica, E; Stafylaki, D | 1 |
1 review(s) available for sisomicin and imipenem, anhydrous
Article | Year |
---|---|
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
9 other study(ies) available for sisomicin and imipenem, anhydrous
Article | Year |
---|---|
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Synthesis and spectrum of the neoglycoside ACHN-490.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Enterobacteriaceae; Microbial Sensitivity Tests; Molecular Structure; Proteus mirabilis; Pseudomonas aeruginosa; Sisomicin | 2010 |
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Combinations; Drug Interactions; Enterococcus faecalis; Imipenem; Microbial Sensitivity Tests; Sisomicin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1984 |
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins | 2015 |
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Indiana; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Sisomicin | 2017 |
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |
Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Boronic Acids; Ceftazidime; Drug Combinations; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Sisomicin; Tetracyclines | 2022 |